Citations (41)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Ernestina Marianna De Francesco, Francesca Cirillo, Veronica Vella, Antonino Belfiore, Marcello Maggiolini & Rosamaria Lappano. (2022) Triple-negative breast cancer drug resistance, durable efficacy, and cure: how advanced biological insights and emerging drug modalities could transform progress. Expert Opinion on Therapeutic Targets 26:6, pages 513-535.
Read now
Read now
Hongchang Li, Zhihua Xia, Limin Liu, Gaofeng Pan, Junbin Ding, Jiazhe Liu, Jie Kang, Jindong Li, Daowen Jiang & Weiyan Liu. (2021) Astragalus IV Undermines Multi-Drug Resistance and Glycolysis of MDA-MB-231/ADR Cell Line by Depressing hsa_circ_0001982-miR-206/miR-613 Axis. Cancer Management and Research 13, pages 5821-5833.
Read now
Read now
Bantari W K Wardhani, Melva Louisa, Yukihide Watanabe, Rianto Setiabudy & Mitsuyasu Kato. (2021) TGF-β-Induced TMEPAI Promotes Epithelial–Mesenchymal Transition in Doxorubicin-Treated Triple-Negative Breast Cancer Cells via SMAD3 and PI3K/AKT Pathway Alteration. Breast Cancer: Targets and Therapy 13, pages 529-538.
Read now
Read now
Articles from other publishers (38)
Gang Yan, Meiou Dai, Sophie Poulet, Ni Wang, Julien Boudreault, Girija Daliah, Suhad Ali & Jean-Jacques Lebrun. (2023) Combined in vitro/in vivo genome-wide CRISPR screens in triple negative breast cancer identify cancer stemness regulators in paclitaxel resistance. Oncogenesis 12:1.
Crossref
Crossref
Klaudia Jomova, Renata Raptova, Suliman Y. Alomar, Saleh H. Alwasel, Eugenie Nepovimova, Kamil Kuca & Marian Valko. (2023) Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging. Archives of Toxicology 97:10, pages 2499-2574.
Crossref
Crossref
Brian M. Lam & Clare Verrill. (2023) Clinical Significance of Tumour-Infiltrating B Lymphocytes (TIL-Bs) in Breast Cancer: A Systematic Literature Review. Cancers 15:4, pages 1164.
Crossref
Crossref
Sergey Vtorushin, Anastasia Dulesova & Nadezhda Krakhmal. (2022) Luminal androgen receptor (LAR) subtype of triple-negative breast cancer: molecular, morphological, and clinical features三阴性乳腺癌的腔内雄激素受体 (LAR) 亚型: 分子、形态和临床特征. Journal of Zhejiang University-SCIENCE B 23:8, pages 617-624.
Crossref
Crossref
Masoumeh Barznegar, Karim Rahimi, Parinaz Mahdavi, Mohammad‐Nazir Menbari, Nikoo Darvishi, Zakaria Vahabzadeh, Mohammad‐Saied Hakhamaneshi, Pedram Andalibi & Mohammad Abdi. (2022)
Relation between the circular and linear form of the
Elongator Acetyltransferase Complex Subunit 3
in the progression of triple‐negative breast cancer
. Cell Biochemistry and Function 40:6, pages 550-558.
Crossref
Crossref
Siti N.H. Muhammad, Nik S. Yaacob, Nur A.M. Safuwan & Agustine N. Fauzi. (2022) Antiglycolytic Activities of Strobilanthes crispus Active Fraction and its Bioactive
Components on Triple-Negative Breast Cancer Cells In Vitro. Anti-Cancer Agents in Medicinal Chemistry 22:7, pages 1363-1369.
Crossref
Crossref
Saeideh Momtaz, Shokoufeh Hassani & Amir Hossein Abdolghaffari. 2022. Antioxidants Effects in Health. Antioxidants Effects in Health
595
612
.
Sugang Ma, Hui Wei, Chunyan Wang, Jixia Han, Xiumin Chen & Yang Li. (2021) MiR-26b-5p inhibits cell proliferation and EMT by targeting MYCBP in triple-negative breast cancer. Cellular & Molecular Biology Letters 26:1.
Crossref
Crossref
Xupeng Bai, Jie Ni, Julia Beretov, Peter Graham & Yong Li. (2021) Immunotherapy for triple-negative breast cancer: A molecular insight into the microenvironment, treatment, and resistance. Journal of the National Cancer Center 1:3, pages 75-87.
Crossref
Crossref
Van T. Hoang, Margarite D. Matossian, Jacqueline La, Kristine Hoang, Deniz A. Ucar, Steven Elliott, Hope E. Burks, Thomas D. Wright, Saloni Patel, Akshita Bhatt, Theresa Phamduy, Douglas Chrisey, Aaron Buechlein, Douglas B. Rusch, Kenneth P. Nephew, Murali Anbalagan, Brian Rowan, Jane E. Cavanaugh, Patrick T. Flaherty, Lucio Miele, Bridgette M. Collins‐Burow & Matthew E. Burow. (2021) Dual inhibition of MEK1/2 and MEK5 suppresses the EMT/migration axis in triple‐negative breast cancer through FRA‐1 regulation. Journal of Cellular Biochemistry 122:8, pages 835-850.
Crossref
Crossref
Mona Al-Mugotir, Jeffrey J. Lovelace, Joseph George, Mika Bessho, Dhananjaya Pal, Lucas Struble, Carol Kolar, Sandeep Rana, Amarnath Natarajan, Tadayoshi Bessho & Gloria E. O. Borgstahl. (2021) Selective killing of homologous recombination-deficient cancer cell lines by inhibitors of the RPA:RAD52 protein-protein interaction. PLOS ONE 16:3, pages e0248941.
Crossref
Crossref
Jinsha Liu, Priyanka Pandya & Sepideh Afshar. (2021) Therapeutic Advances in Oncology. International Journal of Molecular Sciences 22:4, pages 2008.
Crossref
Crossref
S.V. Vtorushin, N.V. Krakhmal & M.V. Zavyalova. (2021) Triple-negative breast cancer. Modern molecular genetic concepts and their clinical significance. Arkhiv patologii 83:3, pages 46.
Crossref
Crossref
Xiaying Zheng, Mengge Huang, Lei Xing, Rui Yang, Xiaosong Wang, Rong Jiang, Luyu Zhang & Junxia Chen. (2020) The circRNA circSEPT9 mediated by E2F1 and EIF4A3 facilitates the carcinogenesis and development of triple-negative breast cancer. Molecular Cancer 19:1.
Crossref
Crossref
Xin-zhi Wang, Yin Feng, Ye-fan Han, Yong Bian, Jie Liang, Hong-mei Wen & Hao Wu. (2020) Budlein A methylacrylate demonstrates potent activity against triple-negative breast cancer by targeting IκBα kinase and exportin-1. Toxicology and Applied Pharmacology 408, pages 115263.
Crossref
Crossref
Hong-Yu Ma, Yang Li, Hui-Zi Yin, Hang Yin, Yuan-Yuan Qu & Qing-Yong Xu. (2020) TNFAIP8 Promotes Cisplatin Chemoresistance in Triple-Negative Breast Cancer by Repressing p53-Mediated miR-205-5p Expression. Molecular Therapy - Nucleic Acids 22, pages 640-656.
Crossref
Crossref
Nan Wen, Qing Lv & Zheng-gui Du. (2020) MicroRNAs involved in drug resistance of breast cancer by regulating autophagyMicroRNAs 通过调节自噬影响乳腺癌的耐药性. Journal of Zhejiang University-SCIENCE B 21:9, pages 690-702.
Crossref
Crossref
Xinhong Pei, Yujie Zhang, Xinxing Wang, Bingjian Xue, Meng Sun & Huixiang Li. (2020) Circular RNA circ-ZEB1 acts as an oncogene in triple negative breast cancer via sponging miR-448. The International Journal of Biochemistry & Cell Biology 126, pages 105798.
Crossref
Crossref
De Zeng, Yuan‐Ke Liang, Ying‐Sheng Xiao, Xiao‐Long Wei, Hao‐Yu Lin, Yang Wu, Jing‐Wen Bai, Min Chen & Guo‐Jun Zhang. (2020)
RETRACTED:
Inhibition of Notch1 reverses EMT and chemoresistance to cisplatin
via
direct downregulation of MCAM in triple‐negative breast cancer cells
. International Journal of Cancer 147:2, pages 490-504.
Crossref
Crossref
Gabrielle Marconi Zago Ferreira Damke, Raquel Pantarotto Souza, Maiara Camotti Montanha, Edilson Damke, Renato Sonchini Gonçalves, Gabriel Batista César, Elza Kimura, Wilker Caetano, Noboru Hioka & Marcia Edilaine Lopes Consolaro. (2020) Selective Photodynamic Effects on Breast Cancer Cells Provided by p123 Pluronic®- Based Nanoparticles Modulating Hypericin Delivery. Anti-Cancer Agents in Medicinal Chemistry 20:11, pages 1352-1367.
Crossref
Crossref
Yepeng Luan, Jinyi Liu, Jianjun Gao & Jinhua Wang. (2019) The Design and Synthesis of Novel Phenothiazine Derivatives as Potential Cytotoxic Agents. Letters in Drug Design & Discovery 17:1, pages 57-67.
Crossref
Crossref
Rui Yang, Lei Xing, Xiaying Zheng, Yan Sun, Xiaosong Wang & Junxia Chen. (2019) RETRACTED ARTICLE: The circRNA circAGFG1 acts as a sponge of miR-195-5p to promote triple-negative breast cancer progression through regulating CCNE1 expression. Molecular Cancer 18:1.
Crossref
Crossref
Siqi Hou, Ming Shan, Chunyang Gao, Xinxin Feng, Yongheng Yang, Ruo Zhang, Yan He, Guoqiang Zhang & Lei Zhang. (2019) PCDHGB7 Increases Chemosensitivity to Carboplatin by Inhibiting HSPA9 via Inducing Apoptosis in Breast Cancer. Disease Markers 2019, pages 1-11.
Crossref
Crossref
Erica Buoso, Melania Ronfani, Marilisa Galasso, Denise Ventura, Emanuela Corsini & Marco Racchi. (2019) Cortisol-induced SRSF3 expression promotes GR splicing, RACK1 expression and breast cancer cells migration. Pharmacological Research 143, pages 17-26.
Crossref
Crossref
Natalia Riobo-Del Galdo, Ángela Lara Montero & Eva Wertheimer. (2019) Role of Hedgehog Signaling in Breast Cancer: Pathogenesis and Therapeutics. Cells 8:4, pages 375.
Crossref
Crossref
Meenakshi Sudhakaran, Sagar Sardesai & Andrea I. Doseff. (2019) Flavonoids: New Frontier for Immuno-Regulation and Breast Cancer Control. Antioxidants 8:4, pages 103.
Crossref
Crossref
Fouzia Guestini, Katsuhiko Ono, Minoru Miyashita, Takanori Ishida, Noriaki Ohuchi, Saki Nakagawa, Hisashi Hirakawa, Kentaro Tamaki, Yasuyo Ohi, Yoshiaki Rai, Yasuaki Sagara, Hironobu Sasano & Keely May McNamara. (2018) Impact of Topoisomerase IIα, PTEN, ABCC1/MRP1, and KI67 on triple-negative breast cancer patients treated with neoadjuvant chemotherapy. Breast Cancer Research and Treatment 173:2, pages 275-288.
Crossref
Crossref
Nataly Naser Al Deen, Farah Nassar, Rihab Nasr & Rabih Talhouk. 2019. Breast Cancer Metastasis and Drug Resistance. Breast Cancer Metastasis and Drug Resistance
335
364
.
Nihad Al-Othman, Hana Hammad & Mamoun Ahram. (2018) Dihydrotestosterone regulates expression of CD44 via miR-328-3p in triple-negative breast cancer cells. Gene 675, pages 128-135.
Crossref
Crossref
Elizabeth Varghese, Samson Samuel, Mariam Abotaleb, Sohaila Cheema, Ravinder Mamtani & Dietrich Büsselberg. (2018) The “Yin and Yang” of Natural Compounds in Anticancer Therapy of Triple-Negative Breast Cancers. Cancers 10:10, pages 346.
Crossref
Crossref
Selcen ARI. (2018) Meme Kanser Kök Hücrelerinde Notch Sinyal Yolağının İnhibisyonunda Güncel YaklaşımlarRecent Applications in Inhibition of Notch Signalling Pathway on Breast Cancer Stem Cell. Marmara Fen Bilimleri Dergisi 30:1, pages 94-104.
Crossref
Crossref
Chandan Kanta Das, Benedikt Linder, Florian Bonn, Florian Rothweiler, Ivan Dikic, Martin Michaelis, Jindrich Cinatl, Mahitosh Mandal & Donat Kögel. (2018) BAG3 Overexpression and Cytoprotective Autophagy Mediate Apoptosis Resistance in Chemoresistant Breast Cancer Cells. Neoplasia 20:3, pages 263-279.
Crossref
Crossref
Hassan Muhammad Yankuzo, Yusha’u Shu’aibu Baraya, Zulkarnain Mustapha, Kah Keng Wong & Nik Soriani Yaacob. (2018) Immunomodulatory effects of a bioactive fraction of Strobilanthes crispus in NMU-induced rat mammary tumor model. Journal of Ethnopharmacology 213, pages 31-37.
Crossref
Crossref
Henan Zhao, Duojiao Li, Baojing Zhang, Yan Qi, Yunpeng Diao, Yuhong Zhen & Xiaohong Shu. (2017) PP2A as the Main Node of Therapeutic Strategies and Resistance Reversal in Triple-Negative Breast Cancer. Molecules 22:12, pages 2277.
Crossref
Crossref
Fouzia Guestini, Keely May McNamara & Hironobu Sasano. (2017) The use of chemosensitizers to enhance the response to conventional therapy in triple-negative breast cancer patients. Breast Cancer Management 6:4, pages 127-131.
Crossref
Crossref
Hongping Zheng, Fangyuan Shao, Scots Martin, Xiaoling Xu & Chu-Xia Deng. (2017) WEE1 inhibition targets cell cycle checkpoints for triple negative breast cancers to overcome cisplatin resistance. Scientific Reports 7:1.
Crossref
Crossref
Elizabeth A. Fry, Pankaj Taneja & Kazushi Inoue. (2017) Oncogenic and tumor-suppressive mouse models for breast cancer engaging HER2/neu. International Journal of Cancer 140:3, pages 495-503.
Crossref
Crossref
Gisela Anton, Pascal Baltzer, Julius Emons, Peter Andreas Fasching, Rüdiger Schulz-Wendtland & Christian Weismann. 2017. Mammadiagnostik. Mammadiagnostik
201
218
.